New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
16:07 EDTDEPODepomed names R. Scott Shively as Chief Commercial Officer
Depomed (DEPO) announced the appointment of R. Scott Shively as Chief Commercial Officer and senior VP. Shively served as executive VP and Chief Commercial Officer of Zogenix (ZGNX) from November 2012 through August where he directed all commercial efforts of the company.
News For DEPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 19, 2015
10:02 EDTDEPOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:22 EDTDEPODepomed downgraded to Neutral at Janney Capital
Subscribe for More Information
08:16 EDTDEPODepomed downgraded to Neutral from Buy at Janney Capital
Subscribe for More Information
March 17, 2015
08:35 EDTDEPODepomed announces expiration of waiting period to acquire rights of NUCYNTA
Depomed announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired with respect to Depomed's pending acquisition of U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals. The termination of the waiting period under the HSR Act satisfies one of the conditions to the closing of the pending acquisition, which remains subject to completion of Depomed's previously announced financing and other customary closing conditions.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use